Skip to content

Effect of intravenous vitamin B6 on the incidence of postoperative nausea and vomiting: a multicenter, randomized controlled study

Effect of intravenous vitamin B6 on the incidence of postoperative nausea and vomiting: a multicenter, randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103438
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

Control group:4 ml of normal saline intravenous infusion is given prior to anesthesia induction
Experimental group:0.2g/4ml vitamin B6 and 2M normal saline intravenous infusion was given before anesthesia induction

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who intend to undergo gynecological laparoscopic surgery, cholecystectomy, otolaryngology surgery, thyroidectomy, and breast surgery under general anesthesia; (2) Age 18~80 years old; (3) ASA Class I.~III; (4) Provide signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Known allergy to VitB6 or use of VitB6 within one week before surgery; (2) Use of long-acting antiemetics and emetic drugs within one week before surgery; (3) Long-term use of opioids or glucocorticoids; (4) Have other medical conditions that may cause nausea and/or vomiting, such as hepatitis or stomach ulcers; (5) Postoperative gastric tube treatment; (6) Pregnancy or lactation; (7) Mental retardation, mental illness or severe neurological disease; (8) Participate in other clinical studies; (9) Refusal to participate in this study.

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting within 24 hours after surgery;

Secondary

MeasureTime frame
Incidence of nausea and vomiting in the early postoperative period;Incidence of nausea and vomiting in late postoperative stages;Incidence of postoperative nausea;Incidence of postoperative vomiting;The severity of the patient's nausea at 24 hours postoperatively (0 none; 1 mild; 2 medium; 3 violent);The severity of the patient's vomiting at 24 hours postoperatively (0 none; 1 mild; 2 medium; 3 violent);Frequency of vomiting (1, 2, >=3);Time to first onset of postoperative nausea and vomiting;Treatment of anti-nausea medications;Maximum pain score at rest/exercise within 24 hours postoperatively;Morphine equivalent dose used within 24 hours postoperatively;Length of hospital stay;

Countries

China

Contacts

Public ContactLe Yuan

Department of Anesthesiology, Third Xiangya Hospital, Central South University

leyuanxy@csu.edu.cn+86 137 8710 7617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026